STRO vs EOLS
Comparison between Sutro Biopharma Inc (STRO, Company) and Evolus Inc (EOLS, Company).
Both STRO and EOLS are from the Healthcare sector.
5-Year PerformanceEOLS has outperformed STRO, delivering a return of -11.3% compared to -33.1%
STRO vs EOLS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
STRO vs EOLS - Historical Returns
Returns include dividend reinvestment.
STRO vs EOLS - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | STRO | EOLS |
|---|---|---|
| 2026 | +108.76% | -11.01% |
| 2025 | -40.05% | -40.14% |
| 2024 | -59.74% | +10.51% |
| 2023 | -46.51% | +34.48% |
| 2022 | -47.22% | +6.98% |
| 2021 | -28.22% | +103.44% |
| 2020 | +81.07% | -72.09% |
| 2019 | +9.02% | -2.09% |
| 2018 | -40.66% | +3.48% |
STRO vs EOLS Drawdown Comparison
The maximum drawdown for STRO was -98.10%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The maximum drawdown for EOLS was -92.41%, occurring on Oct 29, 2020. This drawdown has not yet recovered.
The current STRO drawdown is -91.69%. The current EOLS drawdown is -84.46%.
| Rank | STRO | EOLS |
|---|---|---|
| #1 | -98.10% Jan 22, 2021 - Apr 17, 2025 | -92.41% Jun 6, 2018 - Oct 29, 2020 |
| #2 | -59.28% Sep 27, 2018 - Nov 6, 2020 | -45.20% Mar 16, 2018 - May 11, 2018 |
| #3 | -13.55% Dec 17, 2020 - Jan 7, 2021 | -26.96% May 15, 2018 - May 18, 2018 |
| #4 | -12.49% Nov 17, 2020 - Dec 4, 2020 | -11.07% Feb 21, 2018 - Mar 12, 2018 |
| #5 | -8.27% Nov 9, 2020 - Nov 13, 2020 | -6.49% May 29, 2018 - Jun 1, 2018 |
| #6 | -6.71% Dec 4, 2020 - Dec 16, 2020 | -5.71% May 24, 2018 - May 29, 2018 |
| #7 | -3.18% Jan 15, 2021 - Jan 22, 2021 | -4.37% Mar 12, 2018 - Mar 16, 2018 |
| #8 | -3.15% Jan 8, 2021 - Jan 15, 2021 | -3.43% Feb 9, 2018 - Feb 15, 2018 |
| #9 | N/A | -0.68% Feb 15, 2018 - Feb 20, 2018 |
Correlation
Correlation between STRO and EOLS is 0.03 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks